MedTrace Logo

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination

NCT02003508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.

Conditions

  • Human Papillomavirus

Sponsors & Collaborators

Principal Investigators

  • Marcus Y Chen, PhD · Melbourne Sexual Health Centre Alfred Health and Central Clinical School Monash University

Eligibility

Min Age
17 Years
Max Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-12-29
Completion
2017-12-29

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003508 on ClinicalTrials.gov